Jianing Chen
Keine laufenden Positionen mehr
Karriereverlauf von Jianing Chen
Ehemalige bekannte Positionen von Jianing Chen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IMAX CHINA HOLDING, INC. | Geschäftsführer | 01.08.2023 | 17.05.2024 |
| Finanzdirektor/CFO | 01.08.2023 | 17.05.2024 | |
mProbe, Inc.
 mProbe, Inc. Medical/Nursing ServicesHealth Services mProbe, Inc. is a biotechnology company that focuses on precision medicine, precision health, and predictive healthcare analytics. The private company is based in Palo Alto, CA. The company has developed a proprietary technology platform that integrates artificial intelligence and multi-omic diagnostics to transform the disease prediction, prevention, and cure paradigm. The CEO of the company is Peter Limin. | Finanzdirektor/CFO | 01.11.2019 | 01.08.2023 |
Ausbildung von Jianing Chen
| Oklahoma State University | Graduate Degree |
| Jinan University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| China | 3 |
Operativ
| Director of Finance/CFO | 2 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Electronic Technology | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IMAX CHINA HOLDING, INC. | Electronic Technology |
| Private Unternehmen | 1 |
|---|---|
mProbe, Inc.
mProbe, Inc. Medical/Nursing ServicesHealth Services mProbe, Inc. is a biotechnology company that focuses on precision medicine, precision health, and predictive healthcare analytics. The private company is based in Palo Alto, CA. The company has developed a proprietary technology platform that integrates artificial intelligence and multi-omic diagnostics to transform the disease prediction, prevention, and cure paradigm. The CEO of the company is Peter Limin. | Health Services |
- Börse
- Insiders
- Jianing Chen
- Erfahrung
